Indikation: PelviGYNious ist für die
chirurgische Behandlung des
symptomatischen Beckenorganvorfalls
(pelvic organ
prolapse, POP) im apikalen
Kompartiment vorgesehen,
gegebenenfalls in Kombination
mit:
wobei Harninkontinenz
auftreten kann oder auch
nicht
Transabdominales Netzimplantat zur chirurgischen Behandlung des weiblichen Beckenorganprolapses (POP).
[1] Christmann-Schmid et al. (2018)
Laparoscopic sacrocolpopexy with or without midurethral sling insertion:
Is a two-step approach justified? A prospective study.
[1] Brandt et al. (2019)
1-Year Outcome After Treatment of Uterovaginal Prolapse With a 6-Point Fixation Mesh.
[2] Kuszka et al. (2020)
3 Year outcome after treatment of uterovaginal prolapse with a 6-point fixation mesh.
[3] Deltetto et al. (2021)
Effectiveness and Safety of Posterior Vaginal Repair with Single-Incision, Ultralightweight, Monofilament Propylene Mesh: First Evidence from a Case Series with Short-Term Results.
[4] Mangano et al. (2021)
More than a sacrospinous ligament fixation for prosthetic treatment of utero-vaginal prolapse: a six-point fixation mesh.
[5] Deltetto et al. (2021)
Efficacy and safety of an ultralight, six-point, polypropylene vaginal mesh in the treatment of urogenital prolapse.
[6] Data on file
A.M.I. Agency for Medical Innovations GmbH
Im Letten 1
6800 Feldkirch
Produktrückmeldungen bitte an::
vigilance@ami.at
